Search research articles
Contact Us
Filters
Showing results (1-10 of 137) with videos related to
Page
of 14
Sort By:
Pharmacoepidemiology and Drug Safety
|
October 11, 2025
Dear Pharmacoepidemiology and Outcomes Researcher: It's Time We Had the Transparency Talk
Shirley V Wang
Pharmacoepidemiology and Drug Safety
|
March 16, 2019
Commentary in response to Carrigan et al: "An Evaluation of the Impact of Missing Deaths on Overall Survival Analyses of Advanced Non-small Cell Lung Cancer Patients Conducted in an Electronic Health Records Database"
Shirley V Wang
International Journal of Epidemiology
|
June 11, 2025
Commentary: An example of translational science with tree-temporal scan statistics-building methodological innovations into public health practice
Shirley V Wang
Clinical Epidemiology
|
May 6, 2022
A Framework for Visualizing Study Designs and Data Observability in Electronic Health Record Data
Shirley V Wang, Sebastian Schneeweiss
Pharmacoepidemiology and Drug Safety
|
January 4, 2024
The FAIRification of research in real-world evidence: A practical introduction to reproducible analytic workflows using Git and R
Janick Weberpals, Shirley V Wang
JAMA Internal Medicine
|
February 12, 2024
Hypothetical Assessments of Trial Emulations
Sebastian Schneeweiss, Shirley V Wang
JAMA
|
April 8, 2024
Data Checks Before Registering Study Protocols for Health Care Database Analyses
Shirley V Wang, Sebastian Schneeweiss
American Journal of Epidemiology
|
May 25, 2024
Building transparency and reproducibility into the practice of pharmacoepidemiology and outcomes research
Shirley V Wang, Anton Pottegård
Clinical Pharmacology and Therapeutics
|
September 17, 2024
External Controls to Study Treatment Effects in Rare Diseases: Challenges and Future Directions
Janick Weberpals, Shirley V Wang
JAMA
|
August 22, 2023
Understanding the Facets of Emulating Randomized Clinical Trials-Reply
Shirley V Wang, Sebastian Schneeweiss
Page
of 14
Search research articles
Search
Showing results (1-10 of 137) with videos related to
Sort By:
Page
of 14
Pharmacoepidemiology and Drug Safety
|
October 11, 2025
Dear Pharmacoepidemiology and Outcomes Researcher: It's Time We Had the Transparency Talk
Shirley V Wang
Pharmacoepidemiology and Drug Safety
|
March 16, 2019
Commentary in response to Carrigan et al: "An Evaluation of the Impact of Missing Deaths on Overall Survival Analyses of Advanced Non-small Cell Lung Cancer Patients Conducted in an Electronic Health Records Database"
Shirley V Wang
International Journal of Epidemiology
|
June 11, 2025
Commentary: An example of translational science with tree-temporal scan statistics-building methodological innovations into public health practice
Shirley V Wang
Clinical Epidemiology
|
May 6, 2022
A Framework for Visualizing Study Designs and Data Observability in Electronic Health Record Data
Shirley V Wang, Sebastian Schneeweiss
Pharmacoepidemiology and Drug Safety
|
January 4, 2024
The FAIRification of research in real-world evidence: A practical introduction to reproducible analytic workflows using Git and R
Janick Weberpals, Shirley V Wang
JAMA Internal Medicine
|
February 12, 2024
Hypothetical Assessments of Trial Emulations
Sebastian Schneeweiss, Shirley V Wang
JAMA
|
April 8, 2024
Data Checks Before Registering Study Protocols for Health Care Database Analyses
Shirley V Wang, Sebastian Schneeweiss
American Journal of Epidemiology
|
May 25, 2024
Building transparency and reproducibility into the practice of pharmacoepidemiology and outcomes research
Shirley V Wang, Anton Pottegård
Clinical Pharmacology and Therapeutics
|
September 17, 2024
External Controls to Study Treatment Effects in Rare Diseases: Challenges and Future Directions
Janick Weberpals, Shirley V Wang
JAMA
|
August 22, 2023
Understanding the Facets of Emulating Randomized Clinical Trials-Reply
Shirley V Wang, Sebastian Schneeweiss
Page
of 14